Africa: HIV in South Africa – Why Rolling Out a Groundbreaking New Shot Will Miss a Critical Group of Men

Africa: HIV in South Africa – Why Rolling Out a Groundbreaking New Shot Will Miss a Critical Group of Men

The first shipment of Lenacapavir, a long-acting injectable that prevents HIV with two shots a year, arrived in South Africa from the United States in early April 2026. Clinical trials showed close to 100% efficacy. The rollout, expected to begin in June 2026, prioritises adolescent girls and young women, pregnant and breastfeeding women, transgender people,…

Read More